相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases
Wei-Jian Pan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
High-Throughput Flow Cytometry Data Normalization for Clinical Trials
Greg Finak et al.
CYTOMETRY PART A (2014)
Anti-IL21 Receptor Monoclonal Antibody (ATR-107): Safety, Pharmacokinetics, and Pharmacodynamic Evaluation in Healthy Volunteers: A Phase I, First-in-Human Study
Fei Hua et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
Charlotte Giesen et al.
NATURE METHODS (2014)
Compatibility of Stabilized Whole Blood Products with CD4 Technologies and Their Suitability for Quality Assessment Programs
Tao Ding et al.
PLOS ONE (2014)
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan
Fotios Loupakis et al.
TARGETED ONCOLOGY (2014)
Pharmacokinetics and Pharmacodynamics of ASKP1240, a Fully Human Anti-CD40 Antibody, in Normal and Renal Transplanted Cynomolgus Monkeys
Anlun Ma et al.
TRANSPLANTATION (2014)
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2014)
Quantification of Expression of Antigens Targeted by Antibody-Based Therapy in Chronic Lymphocytic Leukemia
Prashant R. Tembhare et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Paul J. Rutgeerts et al.
GUT (2013)
Normalized Median Fluorescence: An Alternative Flow Cytometry Analysis Method for Tracking Human Embryonic Stem Cell States During Differentiation
Lesley Y. Chan et al.
TISSUE ENGINEERING PART C-METHODS (2013)
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
Mathias Streitz et al.
TRANSPLANTATION RESEARCH (2013)
Brilliant violet fluorophores: A new class of ultrabright fluorescent compounds for immunofluorescence experiments
Pratip K. Chattopadhyay et al.
CYTOMETRY PART A (2012)
Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis
Bing Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer
Daniel J. Freeman et al.
MOLECULAR CANCER (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo
Elizabeth Ward et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Variables Affecting the Quantitation of CD22 in Neoplastic B Cells
Gregory A. Jasper et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2011)
Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
Cherie L. Green et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Recommendations for the validation of flow cytometric testing during drug development: II assays
Denise M. O'Hara et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Stability of immunophenotypic markers in fixed peripheral blood for extended analysis using flow cytometry
Cuc Davis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
PK-PD modeling of protein drugs: implications in assay development
Lorin K. Roskos et al.
BIOANALYSIS (2011)
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Mohammad Tabrizi et al.
AAPS JOURNAL (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
Robert Bissonnette et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Type I Interferon Receptor is a Primary Regulator of Target-Mediated Drug Disposition of Interferon-β in Mice
Anson K. Abraham et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Neutralization of Interferon-alpha/beta-Inducible Genes and Downstream Effect in a Phase I Trial of an Anti-Interferon-alpha Monoclonal Antibody in Systemic Lupus Erythematosus
Yihong Yao et al.
ARTHRITIS AND RHEUMATISM (2009)
Use of pharmacokinetic/pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics
Balaji M. Agoram
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent
Anthony J. Mutsaers et al.
CLINICAL CANCER RESEARCH (2009)
Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies
P. Y. Muller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis
Roger Palframan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Near-infrared Fluorescence Labeled Anti-TAG-72 Monoclonal Antibodies for Tumor Imaging in Colorectal Cancer Xenograft Mice
Peng Zou et al.
MOLECULAR PHARMACEUTICS (2009)
Structural characterization of a human Fc fragment engineered for lack of effector functions
Vaheh Oganesyan et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma
Amanda Cashen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
Norihiro Nishimoto et al.
BLOOD (2008)
Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients
Maria C. Rosario et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma
Martha Q. Lacy et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development
P. J. Lowe et al.
XENOBIOTICA (2007)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Flow cytometry controls, instrument setup, and the determination of positivity
Holden T. Maecker et al.
CYTOMETRY PART A (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ICOS-induced B7h shedding on B cells IsInhibited by TLR7/8 and TLR9
Eric C. Logue et al.
JOURNAL OF IMMUNOLOGY (2006)
The hollow fiber assay for drug responsiveness in the Ewing's sarcoma family of tumors
Esther Marie Bridges et al.
JOURNAL OF PEDIATRICS (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation
M Johnson
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1
G Fätkenheuer et al.
NATURE MEDICINE (2005)
Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry
DE Warrino et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy
WK Bleeker et al.
JOURNAL OF IMMUNOLOGY (2004)
Evaluation of stabilized blood cell products as candidate preparations for quality assessment programs for CD4 T-cell counting
M Bergeron et al.
CYTOMETRY (2002)
Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations
IC Macdougall
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans
A Verbon et al.
JOURNAL OF IMMUNOLOGY (2001)
Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells
M Heinzelmann et al.
IMMUNOPHARMACOLOGY (2000)
分享论文
